Correlation Between Encore Capital and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Encore Capital and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Encore Capital and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Encore Capital Group and BioNTech SE, you can compare the effects of market volatilities on Encore Capital and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Encore Capital with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Encore Capital and BioNTech.

Diversification Opportunities for Encore Capital and BioNTech

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Encore and BioNTech is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Encore Capital Group and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Encore Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Encore Capital Group are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Encore Capital i.e., Encore Capital and BioNTech go up and down completely randomly.

Pair Corralation between Encore Capital and BioNTech

Given the investment horizon of 90 days Encore Capital is expected to generate 7.68 times less return on investment than BioNTech. But when comparing it to its historical volatility, Encore Capital Group is 1.17 times less risky than BioNTech. It trades about 0.01 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  9,850  in BioNTech SE on August 29, 2024 and sell it today you would earn a total of  2,222  from holding BioNTech SE or generate 22.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Encore Capital Group  vs.  BioNTech SE

 Performance 
       Timeline  
Encore Capital Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Encore Capital Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Encore Capital is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
BioNTech SE 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.

Encore Capital and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Encore Capital and BioNTech

The main advantage of trading using opposite Encore Capital and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Encore Capital position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Encore Capital Group and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stocks Directory
Find actively traded stocks across global markets